MACOMICS

macomics-logo

Macomics is an immuno-oncology company. Macomics focus on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours.

#SimilarOrganizations #People #Financial #Website #More

MACOMICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2020-01-01

Address:
Edinburgh, Edinburgh, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.macomics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
7.44 M GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online


Similar Organizations

arch-oncology-logo

Arch Oncology

Arch Oncology is an immuno-oncology company

asgard-therapeutics-logo

Asgard Therapeutics

Asgard Therapeutics is a Biotechnology Company.

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

immuneid-logo

ImmuneID

ImmuneID is a precision immunology company.

imv-logo

IMV

IMV is a clinical-stage immuno-oncology company.

rznomics-logo

Rznomics

Rznomics is a biotechnology company.

Current Employees Featured

s-myatt_image

S. Myatt
S. Myatt Chief Executive Officer @ Macomics
Chief Executive Officer
2021-01-01

jeffrey-pollard_image

Jeffrey Pollard
Jeffrey Pollard Founder Director and Adviser @ Macomics
Founder Director and Adviser

luca-cassetta_image

Luca Cassetta
Luca Cassetta VP Immunology @ Macomics
VP Immunology
2021-08-01

coral-ries_image

Coral Ries
Coral Ries Chief Scientific Officer @ Macomics
Chief Scientific Officer

Founder


coral-ries_image

Coral Ries

jeffrey-pollard_image

Jeffrey Pollard

luca-cassetta_image

Luca Cassetta

s-myatt_image

S. Myatt

Investors List

caribou-property_image

Caribou Property

Caribou Property investment in Seed Round - Macomics

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Seed Round - Macomics

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Seed Round - Macomics

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Seed Round - Macomics

scottish-investment-bank_image

Scottish Investment Bank

Scottish Investment Bank investment in Seed Round - Macomics

Official Site Inspections

http://www.macomics.com Semrush global rank: 6.04 M Semrush visits lastest month: 1.35 K

  • Host name: 109.228.52.133
  • IP address: 109.228.52.133
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Macomics"

Macomics | Macrophage biology. Revealed

At Macomics we are applying our world-leading understanding of macrophage biology to the development of novel therapeutics that directly modulate macrophage activity in diseases …See details»

Macomics Company Profile - Office Locations, Competitors ... - Craft

Macomics is an immuno-oncology company that develops medicines to modulate macrophages for the treatment of cancer, by bringing together cancer biologists. Its target discovery platform …See details»

Macomics - Crunchbase Company Profile & Funding

Macomics is an immuno-oncology company. Macomics focus on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune …See details»

Macomics - LinkedIn

At Macomics we are applying our world-leading understanding of macrophage biology to the development of modality agnostic therapeutics, that directly modulate macrophage activity in …See details»

Member profile: Macomics | BIA - bioindustry.org

Macomics Ltd is an immuno-oncology company with world-leading expertise in macrophage biology, developing precision medicines to modulate macrophages for the treatment of cancer. …See details»

Harnessing the power of macrophage drug discovery - Nature

Building on grounding-breaking research into the immuno-suppressive role of tumor-associated macrophages (TAMs), Macomics has developed a unique platform, ENIGMAC combining a …See details»

Macomics - Org Chart, Teams, Culture & Jobs - The Org

Macomics is an immuno-oncology company. It takes less than ten minutes to set up your company page. It’s free to use - try it out today. View Macomics' up-to-date org chart, open …See details»

Macomics Company Profile 2024: Valuation, Funding & Investors

Where is Macomics headquartered? Macomics is headquartered in Edinburgh, United Kingdom. What is the size of Macomics? Macomics has 17 total employees. What industry is Macomics …See details»

News - Macomics

Aug 12, 2024 · Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, launches today with a £3.2 million seed financing round led by …See details»

Developing therapies targeting tumour specific macrophages

Macomics has overcome the barriers associated with gene editing macrophages. ENIGMACâ„¢ incorporates novel assay systems, unique genome editing methods, supported by multi-omics …See details»

Macomics - VentureRadar

Website: https://www.macomics.com/ Develops precision medicines targeting macrophages for cancer treatment, focusing on immunosuppressive tumor microenvironments and utilizing …See details»

Ono Enters into a Drug Discovery Collaboration Agreement with …

Mar 23, 2023 · Macomics Ltd is an immuno-oncology company with world-leading expertise in macrophage biology, developing precision medicines to modulate macrophages for the …See details»

Macomics, an immuno-oncology company, secures £3.2 million …

Jul 14, 2020 · Macomics, which was spun out from the University of Edinburgh, will use the proceeds of this fundraising round to develop novel, first-in-class immunotherapies designed …See details»

Macomics and the Institute of Oncology Research (IOR,

Jun 19, 2024 · Macomics is exploiting the potential of macrophage-targeted approaches to develop first-in-class medicines to address disease of high unmet medical need.See details»

MacomicsLimited - Nature

Macomics has built a seasoned drug discovery team, with 17 staff working across two sites— EdinburghandCambridge—withKrzysztofWicher joining as VP Drug Discovery from Kymab, …See details»

Macomics announces five additional internationally renowned …

Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has added five new internationally renowned Advisors to …See details»

Macomics - Products, Competitors, Financials, Employees, …

Macomics is a company focused on the field of macrophage biology, operating within the healthcare and biotechnology sectors. The company's main service is the development of …See details»

News Archives - Macomics

Aug 2, 2021 · Started in 2023 in honour of its late co-founder Prof. Jeffrey Pollard, the Challenge set out to raise funds for the charity established as a memorial in his name, now renamed the …See details»

Macomics Unveils its Lead First-in-Class Anti-Pan-LILRB …

Apr 11, 2024 · Macomics Ltd is a macrophage drug discovery company with a world-leading macrophage drug discovery platform, developing first-in-class medicines to deliver …See details»

Macomics secures £4.24 million expansion financing

Jul 29, 2021 · Macomics Limited, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has closed a follow-on financing of £4.24 million …See details»

linkstock.net © 2022. All rights reserved